SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023842
Filing Date
2020-05-11
Accepted
2020-05-11 07:01:37
Documents
84
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20200331.htm 10-Q 1635428
2 EX-31.1 reph-ex311_9.htm EX-31.1 17155
3 EX-31.2 reph-ex312_7.htm EX-31.2 17163
4 EX-32.1 reph-ex321_8.htm EX-32.1 7922
  Complete submission text file 0001564590-20-023842.txt   7439639

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT reph-20200331.xml EX-101.INS 1646230
6 XBRL TAXONOMY EXTENSION SCHEMA reph-20200331.xsd EX-101.SCH 59153
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20200331_cal.xml EX-101.CAL 70699
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20200331_def.xml EX-101.DEF 172244
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20200331_lab.xml EX-101.LAB 496216
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20200331_pre.xml EX-101.PRE 374581
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 20862555
SIC: 2834 Pharmaceutical Preparations